AVITA Medical Inc. (RCEL)
AVITA Medical Statistics
Share Statistics
AVITA Medical has 26.43M shares outstanding. The number of shares has increased by 2.16% in one year.
| Shares Outstanding | 26.43M |
| Shares Change (YoY) | 2.16% |
| Shares Change (QoQ) | 0.53% |
| Owned by Institutions (%) | 25.36% |
| Shares Floating | 26.23M |
| Failed to Deliver (FTD) Shares | 4.81K |
| FTD / Avg. Volume | 2.43% |
Short Selling Information
The latest short interest is 2.45M, so 9.3% of the outstanding shares have been sold short.
| Short Interest | 2.45M |
| Short % of Shares Out | 9.3% |
| Short % of Float | 9.37% |
| Short Ratio (days to cover) | 15.71 |
Valuation Ratios
The PE ratio is -4.21 and the forward PE ratio is 17.33. AVITA Medical's PEG ratio is 0.
| PE Ratio | -4.21 |
| Forward PE | 17.33 |
| PS Ratio | 3.26 |
| Forward PS | 0.5 |
| PB Ratio | 1.33 |
| P/FCF Ratio | -5.75 |
| PEG Ratio | 0 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for AVITA Medical.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 8.18, with a Debt / Equity ratio of 0.
| Current Ratio | 8.18 |
| Quick Ratio | 7.98 |
| Debt / Equity | 0 |
| Debt / EBITDA | -0.01 |
| Debt / FCF | -0.02 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $194.47K |
| Profits Per Employee | $-150.65K |
| Employee Count | 260 |
| Asset Turnover | 0.35 |
| Inventory Turnover | 2.84 |
Taxes
| Income Tax | 52.88K |
| Effective Tax Rate | -0.14% |
Stock Price Statistics
The stock price has increased by 17.84% in the last 52 weeks. The beta is 1.6, so AVITA Medical's price volatility has been higher than the market average.
| Beta | 1.6 |
| 52-Week Price Change | 17.84% |
| 50-Day Moving Average | 8.97 |
| 200-Day Moving Average | 10.13 |
| Relative Strength Index (RSI) | 65.44 |
| Average Volume (20 Days) | 197.98K |
Income Statement
In the last 12 months, AVITA Medical had revenue of 50.56M and earned -39.17M in profits. Earnings per share was -1.57.
| Revenue | 50.56M |
| Gross Profit | 41.69M |
| Operating Income | -40.4M |
| Net Income | -39.17M |
| EBITDA | -39.57M |
| EBIT | n/a |
| Earnings Per Share (EPS) | -1.57 |
Balance Sheet
The company has 26.68M in cash and 449.48K in debt, giving a net cash position of 26.23M.
| Cash & Cash Equivalents | 26.68M |
| Total Debt | 449.48K |
| Net Cash | 26.23M |
| Retained Earnings | -385.72M |
| Total Assets | 126.03M |
| Working Capital | 96.59M |
Cash Flow
In the last 12 months, operating cash flow was -28.04M and capital expenditures -663.94K, giving a free cash flow of -28.71M.
| Operating Cash Flow | -28.04M |
| Capital Expenditures | -663.94K |
| Free Cash Flow | -28.71M |
| FCF Per Share | -1.15 |
Margins
Gross margin is 82.45%, with operating and profit margins of -79.91% and -77.47%.
| Gross Margin | 82.45% |
| Operating Margin | -79.91% |
| Pretax Margin | -77.36% |
| Profit Margin | -77.47% |
| EBITDA Margin | -78.26% |
| EBIT Margin | -79.91% |
| FCF Margin | -56.77% |
Dividends & Yields
RCEL does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for RCEL is $17.5, which is 74.3% higher than the current price. The consensus rating is "Buy".
| Price Target | $17.5 |
| Price Target Difference | 74.3% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
Stock Splits
The last stock split was on Jun 30, 2020. It was a backward split with a ratio of 1:5.
| Last Split Date | Jun 30, 2020 |
| Split Type | backward |
| Split Ratio | 1:5 |
Scores
| Altman Z-Score | 0.45 |
| Piotroski F-Score | 3 |